Colgate-Palmolive (NYSE:CL) Shares Acquired by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund increased its holdings in Colgate-Palmolive (NYSE:CL) by 2.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 317,808 shares of the company’s stock after buying an additional 8,985 shares during the period. Illinois Municipal Retirement Fund’s holdings in Colgate-Palmolive were worth $28,892,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of CL. FMR LLC boosted its holdings in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after buying an additional 2,674,807 shares during the period. Barclays PLC lifted its position in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. State Street Corp lifted its position in Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after purchasing an additional 1,784,411 shares during the last quarter. Nordea Investment Management AB lifted its position in Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after purchasing an additional 1,247,731 shares during the last quarter. Finally, AustralianSuper Pty Ltd lifted its position in Colgate-Palmolive by 941.9% in the 4th quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company’s stock valued at $103,515,000 after purchasing an additional 1,029,364 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of CL opened at $90.10 on Tuesday. The company’s 50 day moving average price is $88.88 and its 200 day moving average price is $95.73. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a market capitalization of $73.12 billion, a PE ratio of 25.60, a PEG ratio of 4.20 and a beta of 0.44. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the business earned $0.87 earnings per share. Research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.22%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 56.82%.

Analyst Ratings Changes

CL has been the topic of several recent research reports. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Piper Sandler dropped their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.